explored the connection between the inflammasome sensor NLRP1 and acquired drug resistance to temozolomide in melanoma, as NACHT, LRR, and PYD domains‐containing protein inflammasomes play a role in IL‐1β maturation and NF‐κB activation. Here, NFKB1 is linked to melanoma.